Robert Glanzman - 16 May 2022 Form 4 Insider Report for Clene Inc. (CLNN)

Role: Chief Medical Officer
Signature: /s/ Jerry Miraglia POA
Issuer symbol: CLNN
Transactions as of: 16 May 2022
Transactions value $: -$9,576
Form type: 4
Filing time: 18 May 2022, 08:34:58 UTC
Previous filing: 16 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CLNN	Common Stock	Sale	-$9,575	-4,717	-31%	$2.03	10,564	16 May 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 represent shares of common stock of Clene Inc. required to by sold by Mr. Glanzman to satisfy tax withholding obligations in connection with the vesting of restricted stock awards. The sale occurred automatically to satisfy the tax withholding obligation to be funded by a "sell to cover" transaction pursuant to a Rule 10b5-1 trading plan and does not represent a discretionary transaction by Mr. Glanzman.

Content

The sales reported in this Form 4 represent shares of common stock of Clene Inc. required to by sold by Mr. Glanzman to satisfy tax withholding obligations in connection with the vesting of restricted stock awards. The sale occurred automatically to satisfy the tax withholding obligation to be funded by a "sell to cover" transaction pursuant to a Rule 10b5-1 trading plan and does not represent a discretionary transaction by Mr. Glanzman.